Prediction of Response to Chemoradiotherapy by Dynamic Changes of Circulating Exosome Levels in Patients with Esophageal Squamous Cell Carcinoma

References

• Dj U, Eo T, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010–1021. doi:10.1007/s12328-020-01237-x
   PubMed Web of Science ®Google Scholar
• Collaborators GBDOC, Nasrollahzadeh D, Safiri S. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastro Hepatol. 2020;5(6):582–597. doi:10.1016/S2468-1253(20)30007-8
   PubMed Web of Science ®Google Scholar
• Watanabe M, Otake R, Kozuki R, et al. Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surg Today. 2020;50(1):12–20. doi:10.1007/s00595-019-01878-7
   PubMed Web of Science ®Google Scholar
• Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation therapy oncology group. JAMA. 1999;281(17):1623–1627. doi:10.1001/jama.281.17.1623
   PubMed Web of Science ®Google Scholar
• Hulshof M, Geijsen ED, Rozema T, et al. Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO study). J Clin Oncol. 2021;39(25):2816–2824. doi:10.1200/JCO.20.03697
   PubMed Web of Science ®Google Scholar
• Xia X, Wu M, Gao Q, Sun X, Ge X. Consolidation chemotherapy rather than induction chemotherapy can prolong the survival rate of inoperable esophageal cancer patients who received concurrent chemoradiotherapy. Curr Oncol. 2022;29(9):6342–6349. doi:10.3390/curroncol29090499
   PubMed Web of Science ®Google Scholar
• Lord AC, D’Souza N, Shaw A, et al. MRI-diagnosed tumor deposits and EMVI status have superior prognostic accuracy to current clinical TNM staging in rectal cancer. Ann Surg. 2022;276(2):334–344. doi:10.1097/SLA.0000000000004499
   PubMed Web of Science ®Google Scholar
• Chen S, Wu Y, Wang S, Wu J, Wu X, Zheng Z. A risk model of gene signatures for predicting platinum response and survival in ovarian cancer. J Ovarian Res. 2022;15(1):39. doi:10.1186/s13048-022-00969-3
   PubMed Web of Science ®Google Scholar
• Reichenbach ZW, Murray MG, Saxena R, et al. Clinical and translational advances in esophageal squamous cell carcinoma. Adv Cancer Res. 2019;144:95–135.
   PubMed Web of Science ®Google Scholar
• Chaber-Ciopinska A, Kiprian D, Kawecki A, Kaminski MF. Surveillance of patients at high-risk of squamous cell esophageal cancer. Best Pract Res Clin Gastro. 2016;30(6):893–900. doi:10.1016/j.bpg.2016.10.003
   PubMed Web of Science ®Google Scholar
• Glennon KI, Maralani M, Abdian N, et al. Rational development of liquid biopsy analysis in renal cell carcinoma. Cancers. 2021;13(22):22. doi:10.3390/cancers13225825
   Web of Science ®Google Scholar
• Li W, Liu JB, Hou LK, et al. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring. Mol Cancer. 2022;21(1):25. doi:10.1186/s12943-022-01505-z
   PubMed Web of Science ®Google Scholar
• Lai JJ, Chau ZL, Chen SY, et al. Exosome processing and characterization approaches for research and technology development. Adv Sci. 2022;9(15):e2103222. doi:10.1002/advs.202103222
   Web of Science ®Google Scholar
• Paskeh MDA, Entezari M, Mirzaei S, et al. Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. J Hematol Oncol. 2022;15(1):83. doi:10.1186/s13045-022-01305-4
   PubMed Web of Science ®Google Scholar
• Jing Z, Chen K, Gong L. The significance of exosomes in pathogenesis, diagnosis, and treatment of esophageal cancer. Int J Nanomed. 2021;16:6115–6127. doi:10.2147/IJN.S321555
   PubMed Web of Science ®Google Scholar
• Yu D, Li Y, Wang M, et al. Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer. 2022;21(1):56. doi:10.1186/s12943-022-01509-9
   PubMed Web of Science ®Google Scholar
• Zhao A, Guo L, Xu J, et al. Identification and validation of circulating exosomes-based liquid biopsy for esophageal cancer. Cancer Med. 2019;8(7):3566–3574. doi:10.1002/cam4.2224
   PubMed Web of Science ®Google Scholar
• Liu S, Lin Z, Zheng Z, et al. Serum exosomal microRNA-766-3p expression is associated with poor prognosis of esophageal squamous cell carcinoma. Cancer Sci. 2020;111(10):3881–3892. doi:10.1111/cas.14550
   PubMed Web of Science ®Google Scholar
• Chen F, Xu B, Li J, et al. Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10. J Exp Clin Cancer Res. 2021;40(1):38. doi:10.1186/s13046-021-01834-9
   PubMed Web of Science ®Google Scholar
• Luo A, Zhou X, Shi X, et al. Exosome-derived miR-339-5p mediates radiosensitivity by targeting Cdc25A in locally advanced esophageal squamous cell carcinoma. Oncogene. 2019;38(25):4990–5006. doi:10.1038/s41388-019-0771-0
   PubMed Web of Science ®Google Scholar
• Yu W, Hurley J, Roberts D, et al. Exosome-based liquid biopsies in cancer: opportunities and challenges. Ann Oncol. 2021;32(4):466–477. doi:10.1016/j.annonc.2021.01.074
   PubMed Web of Science ®Google Scholar
• Zhu L, Sun HT, Wang S, et al. Isolation and characterization of exosomes for cancer research. J Hematol Oncol. 2020;13(1):152. doi:10.1186/s13045-020-00987-y
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhu Q, Cheng L, et al. Exosome detection via the ultrafast-isolation system: EXODUS. Nat Methods. 2021;18(2):212–218. doi:10.1038/s41592-020-01034-x
   PubMed Web of Science ®Google Scholar
• Yao B, Tan B, Wang C, et al. Comparison of definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma. Ann Surg Oncol. 2016;23(7):2367–2372. doi:10.1245/s10434-016-5154-y
   PubMed Web of Science ®Google Scholar
• Hsieh JC, Chiang PC, Hung TM, et al. Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5-fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real-world evidence. Cancer Med. 2021;10(23):8300–8309. doi:10.1002/cam4.4025
   PubMed Web of Science ®Google Scholar
• Kandiah K, Chedgy FJ, Subramaniam S, Thayalasekaran S, Kurup A, Bhandari P. Early squamous neoplasia of the esophagus: the endoscopic approach to diagnosis and management. Saudi J Gastroenterol. 2017;23(2):75–81. doi:10.4103/1319-3767.203366
   PubMed Web of Science ®Google Scholar
• Visaggi P, Barberio B, Ghisa M, et al. Modern diagnosis of early esophageal cancer: from blood biomarkers to advanced endoscopy and artificial intelligence. Cancers. 2021;13(13):3162. doi:10.3390/cancers13133162
   PubMed Web of Science ®Google Scholar
• Chu LY, Peng YH, Weng XF, Xie JJ, Xu YW. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma. World J Gastroenterol. 2020;26(15):1708–1725. doi:10.3748/wjg.v26.i15.1708
   PubMed Web of Science ®Google Scholar
• Liang LJ, Yang Y, Wei WF, et al. Tumor-secreted exosomal Wnt2B activates fibroblasts to promote cervical cancer progression. Oncogenesis. 2021;10(3):30. doi:10.1038/s41389-021-00319-w
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li F, Wan Y, et al. Cancer-secreted exosomal MiR-620 inhibits ESCC aerobic glycolysis via FOXM1/HER2 pathway and promotes metastasis. Front Oncol. 2022;12:756109. doi:10.3389/fonc.2022.756109
   PubMed Web of Science ®Google Scholar
• Bhat EA, Sajjad N, Thokar FM. Current advancement of exosomes as biomarkers for cancer diagnosis and forecasting. Cancer Treat Res Commun. 2021;28:100417. doi:10.1016/j.ctarc.2021.100417
   PubMedGoogle Scholar
• Zhu Z, Wang H, Pang Y, Hu H, Zhang H, Wang W. Exosomal long non-coding RNA UCA1 functions as growth inhibitor in esophageal cancer. Aging. 2020;12(20):20523–20539. doi:10.18632/aging.103911
   PubMedGoogle Scholar
• Fan L, Cao Q, Liu J, Zhang J, Li B. Circular RNA profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis. Mol Cancer. 2019;18(1):16. doi:10.1186/s12943-018-0936-4
   PubMed Web of Science ®Google Scholar
• Thone MN, Kwon YJ. Extracellular blebs: artificially-induced extracellular vesicles for facile production and clinical translation. Methods. 2020;177:135–145. doi:10.1016/j.ymeth.2019.11.007
   PubMed Web of Science ®Google Scholar
• Maas SL, Broekman ML, de Vrij J. Tunable resistive pulse sensing for the characterization of extracellular vesicles. Methods Mol Biol. 2017;1545:21–33.
   PubMedGoogle Scholar
• Liu Q, Xiang Y, Yuan S, et al. Plasma exosome levels in non-small-cell lung cancer: correlation with clinicopathological features and prognostic implications. Cancer Biomark. 2018;22(2):267–274. doi:10.3233/CBM-170955
   PubMed Web of Science ®Google Scholar
• Tengler L, Schutz J, Tiedtke M, et al. Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients. Mol Med. 2023;29(1):69. doi:10.1186/s10020-023-00659-w
   PubMed Web of Science ®Google Scholar
• Joncas FH, Lucien F, Rouleau M, et al. Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients. Prostate. 2019;79(15):1767–1776. doi:10.1002/pros.23901
   PubMed Web of Science ®Google Scholar
• Khan NA, Asim M, Biswas KH, et al. Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts. J Exp Clin Cancer Res. 2023;42(1):221. doi:10.1186/s13046-023-02753-7
   PubMed Web of Science ®Google Scholar
• Yang Y, Kannisto E, Yu G, Reid ME, Patnaik SK, Wu Y. An immuno-biochip selectively captures tumor-derived exosomes and detects exosomal RNAs for cancer diagnosis. ACS Appl Mater Interfaces. 2018;10(50):43375–43386. doi:10.1021/acsami.8b13971
   PubMed Web of Science ®Google Scholar
• Mondal SK, Whiteside TL. Immunoaffinity-based isolation of melanoma cell-derived and t cell-derived exosomes from plasma of melanoma patients. Methods Mol Biol. 2021;2265:305–321.
   PubMedGoogle Scholar
• Caradec J, Kharmate G, Hosseini-Beheshti E, Adomat H, Gleave M, Guns E. Reproducibility and efficiency of serum-derived exosome extraction methods. Clin Biochem. 2014;47(13–14):1286–1292. doi:10.1016/j.clinbiochem.2014.06.011
   PubMed Web of Science ®Google Scholar